Navigation Links
Agendia Appoints New Chief Financial Officer
Date:1/8/2009

HUNTINGTON BEACH, California, and AMSTERDAM, January 8 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, today announced the appointment of Kurt Schmidt, CPA, MBA, as the company's new Chief Financial Officer.

"Kurt is an exceptional addition to our team and an invaluable asset," said Bernhard Sixt, Ph.D., President and Chief Executive Officer. "With his extensive financial management experience in the high tech and healthcare industries, he will be instrumental in driving Agendia's next phase of growth."

Mr. Schmidt succeeds former Chief Financial Officer, John de Die, who has been an exemplary guide for Agendia during his tenure. Mr. Schmidt brings more than 25 years of financial, operational and entrepreneurial management experience, primarily in the high tech and healthcare industries in the U.S. and Europe. Most recently, he was a principal at a consulting firm he founded in 2002, providing high-level interim financial management and M&A services. Prior to that, Mr. Schmidt served as Operations Director at B2eMarkets, a supply chain technology company, and Director of Finance & Operations at LA Gear Europe. Mr. Schmidt started his career at Cardinal Health, Inc. in corporate finance.

"I am delighted to join Agendia during this exciting time and help prepare the company for our next financing round. I look forward to our first investor meetings next week during the JP Morgan Healthcare Conference in San Francisco," commented Kurt Schmidt, Chief Financial Officer.

About Agendia

Agendia is at the forefront of the personalized medicine revolution, striving to bring more effective, individualized treatments within reach of patients. Building on a cutting edge genomics platform for tumor gene expression profiling, the company's tests aim to help physicians more accurately tailor cancer treatments. The company markets four products, with several new genomic tests under development. In addition, Agendia collaborates with pharmaceutical companies to develop highly effective personalized drugs in the area of oncology. Agendia was awarded the 2008 North American Oncology Clinical Diagnostics Healthcare Innovation Award by Frost & Sullivan. Agendia is based in Huntington Beach, California, and in Amsterdam, The Netherlands. For more information please visit http://www.agendia.com.


'/>"/>
SOURCE Agendia B.V.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Agendia and Ferrer Announce Exclusive Agreement for Sales of Cancer Diagnostic Services in Four Major European Markets
2. Agendias MammaPrint(R) Receives Prestigious Award From Dutch Innovation Platform
3. Agendia and Agilent Announce Plans to Jointly Develop New Diagnostic Tests, Extend Supply Agreement
4. Agendia BV Appoints Clinical and Scientific Advisory Board
5. Agendia BV Announces That its Chief Research Officer Laura van t Veer has Received a 2007 Breast Cancer Research Foundation Award
6. Agendia Acquires Rights to the Discovery of a Major Drug Resistance Mechanism in Breast Cancer Potentially Leading to a Herceptin(R) Sensitivity Test
7. Agendia Joins the Personalized Medicine Coalition (PMC)
8. Agendia BV Appoints Mr. Hessel Lindenbergh as Chairman of its Supervisory Board
9. Kiadis Pharma Appoints Dr. Maarten Egeler, MD PhD as Chief Medical Officer
10. Epitomics Appoints Dr. Zhiqiang An as Chief Scientific Officer
11. Algeta Appoints Andrew Kay as President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... ... Supplies of the critical medical isotope molybdenum-99 (Mo-99) are secure and reliable ... and Molecular Imaging (SNMMI) 2017 annual meeting in Denver, Colorado in June. Mo-99 ... million nuclear medicine procedures worldwide every year. (1) , Sally Schwarz, President of ...
(Date:6/27/2017)... ... June 27, 2017 , ... Brain State Technologies, a ... campaign on June 15th to fund production of the new B2v2 wearable brainwave ... Kickstarter goal by more than 150% in a little over a week. , ...
(Date:6/27/2017)... ... June 27, 2017 , ... Indiana-based Xylogenics ... yeast production and fermentation process. The efficiencies created by the newest strain ... most notably the ethanol industry wherein individual production plants are planning to invest ...
(Date:6/26/2017)... ... 2017 , ... Third Wave Bioactives, LLC announces the addition of Brett Thompson. ... business development and ensuring quality customer experience. , Brett brings to Third ... technical, marketing and sales roles. “Brett’s background working with customers and eye for market ...
Breaking Biology Technology:
(Date:4/13/2017)... UBM,s Advanced Design and Manufacturing event in ... and evolving technology through its 3D Printing and Smart ... the expo portion of the event and feature a ... on trending topics within 3D printing and smart manufacturing. ... will take place June 13-15, 2017 at the Jacob K. ...
(Date:4/11/2017)... 11, 2017 Research and Markets has announced ... report to their offering. ... global eye tracking market to grow at a CAGR of 30.37% ... Tracking Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
Breaking Biology News(10 mins):